Bexion Pharmaceuticals
Corporate Video
Bexion Milestones

Making Significant Progress

Bexion Media
PRESS RELEASE
Bexion Pharmaceuticals Announces Database Lock in Phase 1 Trial of BXQ-350
December 10, 2020
FOR IMMEDIATE RELEASE Covington, KY, December 10, 2020 Bexion Pharmaceuticals, Inc., a clinical stage biotech company focused on the discovery and development of life-changing treatments by leveraging the lysosome’s roles in solid tumors and cell death with an initial focus on cancer, announced today the database lock for the Phase 1 study of BXQ-350 in adult patients […]
read more
Cincinnati Enquirer: 8 Cincinnati biotech companies with big steps to watch in 2020
January 1, 2020